0.940
-0.01 (-0.78%)
| Previous Close | 0.948 |
| Open | 0.980 |
| Volume | 481,787 |
| Avg. Volume (3M) | 663,815 |
| Market Cap | 63,141,628 |
| Price / Earnings (Forward) | 31.75 |
| Price / Sales | 250.06 |
| Price / Book | 1.35 |
| 52 Weeks Range | |
| Earnings Date | 12 Aug 2025 - 18 Aug 2025 |
| Diluted EPS (TTM) | -0.640 |
| Total Debt/Equity (MRQ) | 0.48% |
| Current Ratio (MRQ) | 16.19 |
| Operating Cash Flow (TTM) | -9.28 M |
| Levered Free Cash Flow (TTM) | -5.26 M |
| Return on Assets (TTM) | -40.06% |
| Return on Equity (TTM) | -66.48% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Microbot Medical Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 3.0 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -2.5 |
| Relative Valuation | NA |
| Financial Health | NA |
| AI Insight | NA |
| Weighted Average | 1.83 |
Select this tab to load the latest available analysis.
|
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot’s LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Institutions | 6.26% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Mitsubishi Ufj Asset Management Co., Ltd. | 30 Jun 2026 | 1,268,453 |
| Alphacentric Advisors Llc | 30 Jun 2026 | 250,000 |
No data within this time range.
No data within this time range.
AI Technical Analysis
Open the Technical tab to generate the latest analysis.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |